{"id":834390,"date":"2025-04-07T08:07:16","date_gmt":"2025-04-07T12:07:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/"},"modified":"2025-04-07T08:07:16","modified_gmt":"2025-04-07T12:07:16","slug":"solid-biosciences-to-participate-at-upcoming-investor-conferences-6","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/","title":{"rendered":"Solid Biosciences to Participate at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CHARLESTOWN, Mass., April  07, 2025  (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB) (the \u201cCompany\u201d or \u201cSolid\u201d), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>24th Annual Needham Virtual Healthcare Conference<\/strong>\n        <\/li>\n<\/ul>\n<p>Bo Cumbo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will present on Thursday, April 10, 2025, at 2:15 pm ET.<\/p>\n<p>A live webcast of the presentation will be available on the Events page of the Investors section of the Company website or by <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pOW7yMkKT7pRfv7EpAqigu2duCW2cZUuwQ57jO7fp-BhLwpQdkjcVHoNzHHLZQ6eZJe026RAo31DO0cDfg1PNsC7kZB6YCtw8bSe5TZlEaLZ9G4HECr0Qf966mLimmd7\" rel=\"nofollow\" target=\"_blank\">clicking here<\/a>. The webcast replay will be archived for 90 days on the Events page.<\/p>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Piper Sandler Spring Biopharma Symposium \u2013 Boston, MA<\/strong><br \/>\n          \n        <\/li>\n<\/ul>\n<p align=\"justify\">Management will participate in one-on-one meetings on Thursday, April 17, 2025.<\/p>\n<p align=\"justify\">Institutional investors interested in meeting with management during the conference may reach out to their Needham or Piper Sandler representatives.<\/p>\n<p align=\"justify\">\n        <strong>About Solid Biosciences<\/strong><br \/>\n        <br \/>Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy (Duchenne), Friedreich\u2019s ataxia (FA), catecholaminergic polymorphic ventricular tachycardia (CPVT), TNNT2-mediated dilated cardiomyopathy, BAG3-mediated dilated cardiomyopathy, and additional fatal, genetic cardiac diseases. The Company is also focused on developing innovative libraries of genetic regulators and other enabling technologies with promising potential to significantly impact gene therapy delivery cross-industry. Solid is advancing its diverse pipeline and delivery platform in the pursuit of uniting experts in science, technology, disease management, and care. Patient-focused and founded by those directly impacted by Duchenne, Solid\u2019s mission is to improve the daily lives of patients living with devastating rare diseases. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=38SSaKmVcbNerUjBgVB_Mx7YdHZtwlDLLM0YO1Gs-0XoApg7dsZ89oIqgPPFJPVaamb74XV2q1Hg8d7x3J-LMjQw48hRPLkpo4SCxgI5FIw=\" rel=\"nofollow\" target=\"_blank\">www.solidbio.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Solid Biosciences Investor Contact:<\/strong><br \/>\n        <br \/>Nicole Anderson<br \/>Director, Investor Relations and Corporate Communications<br \/>Solid Biosciences Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WSFcwU1FoKkxTXCNqa6IZS89AXCJNDL_2YnYg6-W1rl_NupsJ0sBqznRluy6s-nXfv2tAwwOVeIfguo6rCbE4MqMnTdWV3IEANkbRDqIZokyDbj5vuB8CAMGFDzh_j-pij_994wlioQ4lvvXcYKaykdEYule69NorKE7CviTTiD8fblPqNbCjVaeo0a3tKknZKNK6DZeWmzhQgZo1w5HXP4qXEhUucOzMe8jgf9SkmKXrZUIcr0q82fiHC6QCg5ovGaDsOaozj_D8h2zBu6kSw==\" rel=\"nofollow\" target=\"_blank\">investors@solidbio.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Glenn Silver<br \/>FINN Partners<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RV-0J_3hXFwXyVlmofylCCJzD4YX7woHWrZk5Uh7w1Rvo1P76vse854RYjw1N0Y04oGhzZwXUaY8N_N6nZj2G4ToBR4cPz8F-qHkq8TqhqaEWdrXV1gInpFoXW_W2dkNnY55qk17HarciSpB5nH1_aW-6IDPdNe6XdpFcY7aeEcpQJ9Bm2dZ6YOuQXmTe_XxeeUhE2PNooBy1NaYO4wHuY1J7lws1anu1Zy55uOwVfnyz--cRG5QwqtmKe2rNMMXEOtbdUFFFW2HHm5RnSHPq906hQydiCDTZMw3b2rm11L-OMLYojt5URVVZtqnTtaG\" rel=\"nofollow\" target=\"_blank\">glenn.silver@finnpartners.com<\/a><\/p>\n<p>This press release was published by a CLEAR\u00ae Verified individual.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzQzNiM2ODUxNTEwIzIwOTExOTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzEwNDQ3ZWQtZmY5Ni00YWQyLWExM2YtYzlmNmIzMTkxOGY3LTExMDI3NjgtMjAyNS0wNC0wNy1lbg==\/tiny\/Solid-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHARLESTOWN, Mass., April 07, 2025 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB) (the \u201cCompany\u201d or \u201cSolid\u201d), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences: 24th Annual Needham Virtual Healthcare Conference Bo Cumbo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will present on Thursday, April 10, 2025, at 2:15 pm ET. A live webcast of the presentation will be available on the Events page of the Investors section of the Company website or by clicking here. The webcast replay will be archived for 90 days on the Events page. Piper Sandler Spring Biopharma Symposium \u2013 Boston, MA Management will participate in one-on-one meetings on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Solid Biosciences to Participate at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-834390","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Solid Biosciences to Participate at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Solid Biosciences to Participate at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHARLESTOWN, Mass., April 07, 2025 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB) (the \u201cCompany\u201d or \u201cSolid\u201d), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences: 24th Annual Needham Virtual Healthcare Conference Bo Cumbo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will present on Thursday, April 10, 2025, at 2:15 pm ET. A live webcast of the presentation will be available on the Events page of the Investors section of the Company website or by clicking here. The webcast replay will be archived for 90 days on the Events page. Piper Sandler Spring Biopharma Symposium \u2013 Boston, MA Management will participate in one-on-one meetings on &hellip; Continue reading &quot;Solid Biosciences to Participate at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-07T12:07:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzQzNiM2ODUxNTEwIzIwOTExOTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Solid Biosciences to Participate at Upcoming Investor Conferences\",\"datePublished\":\"2025-04-07T12:07:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\\\/\"},\"wordCount\":314,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNzQzNiM2ODUxNTEwIzIwOTExOTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\\\/\",\"name\":\"Solid Biosciences to Participate at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNzQzNiM2ODUxNTEwIzIwOTExOTc=\",\"datePublished\":\"2025-04-07T12:07:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNzQzNiM2ODUxNTEwIzIwOTExOTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNzQzNiM2ODUxNTEwIzIwOTExOTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Solid Biosciences to Participate at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Solid Biosciences to Participate at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/","og_locale":"en_US","og_type":"article","og_title":"Solid Biosciences to Participate at Upcoming Investor Conferences - Market Newsdesk","og_description":"CHARLESTOWN, Mass., April 07, 2025 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB) (the \u201cCompany\u201d or \u201cSolid\u201d), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences: 24th Annual Needham Virtual Healthcare Conference Bo Cumbo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will present on Thursday, April 10, 2025, at 2:15 pm ET. A live webcast of the presentation will be available on the Events page of the Investors section of the Company website or by clicking here. The webcast replay will be archived for 90 days on the Events page. Piper Sandler Spring Biopharma Symposium \u2013 Boston, MA Management will participate in one-on-one meetings on &hellip; Continue reading \"Solid Biosciences to Participate at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-07T12:07:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzQzNiM2ODUxNTEwIzIwOTExOTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Solid Biosciences to Participate at Upcoming Investor Conferences","datePublished":"2025-04-07T12:07:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/"},"wordCount":314,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzQzNiM2ODUxNTEwIzIwOTExOTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/","name":"Solid Biosciences to Participate at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzQzNiM2ODUxNTEwIzIwOTExOTc=","datePublished":"2025-04-07T12:07:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzQzNiM2ODUxNTEwIzIwOTExOTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzQzNiM2ODUxNTEwIzIwOTExOTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-upcoming-investor-conferences-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Solid Biosciences to Participate at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/834390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=834390"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/834390\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=834390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=834390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=834390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}